Aaron P Turner1, Lindsey M Knowles1. 1. is Director of Rehabilitation Psychology at VA Puget Sound Health Care System and a Professor at the University of Washington Department of Rehabilitation Medicine, both in Seattle. is a Senior Fellow in the MS Center of Excellence, VA Puget Sound Health Care System and in the University of Washington Department of Medicine.
Abstract
IMPORTANCE: Multiple sclerosis (MS) is a complex and unpredictable neurologic disease affecting nearly 1 million people in the US. People with MS commonly experience multiple physical and psychological symptoms such as depression, anxiety, stress, fatigue, and pain that impact functioning and quality of life. Subsequently, living with MS requires routine management of MS symptoms, adaptation to challenges, and engagement in health behaviors to promote well-being over time. OBSERVATIONS: There is considerable evidence that behavioral interventions that increase cognitive and/or behavioral skills to address the challenges of day-to-day life with MS can promote resilience and reduce overall distress associated with this chronic and unpredictable disease. Brief group-based cognitive-behavioral therapy (CBT) and CBT-based interventions (eg, self-management) have been shown to reduce symptoms of depression, anxiety, stress, fatigue, and pain in people with MS, including via telehealth delivery. Likewise, mindfulness-based interventions have been shown to improve depression, anxiety, stress, fatigue, and quality of life in people with MS. Behavioral interventions also have been shown to improve health behaviors such as physical activity and adherence to disease modifying therapies in MS. Unlike other treatment options, behavioral interventions can be delivered in various formats (eg, in-person, telehealth), are time-limited, and cause few (if any) undesirable systemic side effects. CONCLUSIONS: Behavioral intervention is an integral component of interprofessional care and key aspect of living well with MS.
IMPORTANCE: Multiple sclerosis (MS) is a complex and unpredictable neurologic disease affecting nearly 1 million people in the US. People with MS commonly experience multiple physical and psychological symptoms such as depression, anxiety, stress, fatigue, and pain that impact functioning and quality of life. Subsequently, living with MS requires routine management of MS symptoms, adaptation to challenges, and engagement in health behaviors to promote well-being over time. OBSERVATIONS: There is considerable evidence that behavioral interventions that increase cognitive and/or behavioral skills to address the challenges of day-to-day life with MS can promote resilience and reduce overall distress associated with this chronic and unpredictable disease. Brief group-based cognitive-behavioral therapy (CBT) and CBT-based interventions (eg, self-management) have been shown to reduce symptoms of depression, anxiety, stress, fatigue, and pain in people with MS, including via telehealth delivery. Likewise, mindfulness-based interventions have been shown to improve depression, anxiety, stress, fatigue, and quality of life in people with MS. Behavioral interventions also have been shown to improve health behaviors such as physical activity and adherence to disease modifying therapies in MS. Unlike other treatment options, behavioral interventions can be delivered in various formats (eg, in-person, telehealth), are time-limited, and cause few (if any) undesirable systemic side effects. CONCLUSIONS: Behavioral intervention is an integral component of interprofessional care and key aspect of living well with MS.
Authors: B Wood; I A F van der Mei; A-L Ponsonby; F Pittas; S Quinn; T Dwyer; R M Lucas; B V Taylor Journal: Mult Scler Date: 2012-06-22 Impact factor: 6.312
Authors: Aaron P Turner; Narineh Hartoonian; Alicia P Sloan; Marisa Benich; Daniel R Kivlahan; Christina Hughes; Abbey J Hughes; Jodie K Haselkorn Journal: J Consult Clin Psychol Date: 2016-02-25
Authors: Aaron P Turner; Rhonda M Williams; James D Bowen; Daniel R Kivlahan; Jodie K Haselkorn Journal: Arch Phys Med Rehabil Date: 2006-08 Impact factor: 3.966
Authors: Peter W Thomas; Sarah Thomas; Paula Kersten; Rosemary Jones; Alison Nock; Vicky Slingsby; Colin Green; Roger Baker; Kate Galvin; Charles Hillier Journal: BMC Neurol Date: 2010-06-16 Impact factor: 2.474
Authors: Ruth Ann Marrie; Stephen Reingold; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sorensen; Gary Cutter; Nadia Reider Journal: Mult Scler Date: 2015-01-12 Impact factor: 6.312